Related Experiment Videos
Engineering chemical reactivity on cell surfaces through oligosaccharide biosynthesis
L K Mahal1, K J Yarema, C R Bertozzi
1Department of Chemistry, University of California, Berkeley, CA 94720, USA.
Summary
Researchers engineered cell surfaces with ketone groups using a modified sugar. This allows precise chemical modification for applications like targeted drug delivery and cell recognition.
Area of Science:
- Biochemistry
- Chemical Biology
- Cell Biology
Background:
- Cell surface oligosaccharides play crucial roles in biological recognition.
- Modifying cell surface chemistry enables new functionalization strategies.
- Metabolic incorporation of unnatural sugars offers a route to novel cell surface functionalities.
Purpose of the Study:
- To develop a method for metabolically incorporating ketone groups onto cell surfaces.
- To demonstrate the utility of cell surface ketone groups for selective chemical ligation.
- To showcase the potential of this technology in applications like targeted drug delivery.
Main Methods:
- Metabolic incorporation of an unnatural N-acetyl-mannosamine derivative containing a ketone group into cell surface oligosaccharides.
- Selective covalent ligation of ketone groups with hydrazide-functionalized molecules under physiological conditions.
- Demonstration of targeted cell killing using ricin A chain-avidin conjugate mediated by cell surface biotinylation.
Main Results:
- Successfully generated cells displaying ketone groups on their surface via metabolic glycoengineering.
- Validated the ability to selectively conjugate hydrazide-bearing molecules to cell surface ketone groups.
- Achieved targeted cell decoration with biotin and subsequent selective cell killing, demonstrating drug delivery potential.
Conclusions:
- Metabolic glycoengineering provides a powerful tool for introducing ketone functionalities onto cell surfaces.
- Cell surface ketone groups enable selective chemical remodeling for diverse biological applications.
- This technology holds promise for advancing targeted therapies and cell-based assays.